Clindamycin Phosphate Injection Shortage: Supply Updates and Manufacturer Status

What’s in Shortage

Clindamycin Phosphate Injection, an anti-infective medication, is currently listed as being in shortage. This shortage affects several presentations of the drug, including brand names CLINDAMYCIN PHOSPHATE, CLINDAMYCIN IN 5 PERCENT DEXTROSE, and CLINDAMYCIN. The medication is administered in an injection dosage form. This shortage was first posted on March 21, 2023, and was last updated on February 2, 2026.

Which Manufacturers Are Affected

Several manufacturers are involved in the supply of Clindamycin Phosphate Injection, with varying levels of availability:

• Baxter Healthcare (888-229-0001):
  • Unavailable: 300 mg/50 mL (NDC 0338-9549-50), 900 mg/50 mL (NDC 0338-9553-50), and 600 mg/50 mL (NDC 0338-3612-50). Estimated recovery for these is March 2026.
  • Limited Availability: 900 mg/50 mL (NDC 0338-3814-50). Recovery date is currently TBD.
  • Available: Certain 300 mg/50 mL presentations (NDC 0338-3410-50 and 0338-9545-50).
• Sandoz Inc. (800-525-8747):
  • Available: Multiple presentations including 12 mg/1 mL, 18 mg/1 mL, and 6 mg/1 mL in various containers (some under the Civica Label).
• Sagent Pharmaceuticals (866-625-1618):
  • Available: 150 mg/1 mL presentations (NDC 25021-115-06, 25021-115-04, 25021-115-02).

Why There’s a Shortage

According to the FDA, the primary reason for the current shortage is a demand increase for the drug.

What Patients Should Do

If you or a loved one are prescribed Clindamycin Phosphate Injection, please consider the following steps:

• Consult Your Healthcare Provider: Speak with your doctor regarding your treatment plan and any concerns about medication availability.
• Talk to Your Pharmacist: Pharmacists often have the most up-to-date information on local stock and can coordinate with providers if a specific presentation is unavailable.
• Contact Manufacturers: For specific questions regarding supply timelines for certain NDCs, you may contact the manufacturers directly using the phone numbers provided above.

Disclaimer: Patients should always consult their healthcare provider for medical advice and treatment options. Do not alter your medication regimen without professional medical guidance.

Source

Information provided by the FDA Drug Shortage Database.